- Current languageen
Pharmaceuticals - Community Register
Community list of not active veterinary medicinal products
|Invented name:||Purevax RCCh|
|Auth. number :||EU/2/04/049|
|Active substance :||Not available|
|ATC:||Anatomical main group: QI - Immunologicals|
Therapeutic subgroup: QI06 - Immunologicals for felidae
Pharmacological subgroup: QI06A - Cat
Chemical subgroup: QI06AH - Live and inactivated viral vaccines
Chemical substance: QI06AH - Live and inactivated viral vaccines
(See WHO ATCvet Index)
|Indication:||Active immunisation of cats aged 8 weeks and older:|
- against feline viral rhinotracheitis to reduce clinical signs,
- against calicivirus infection to reduce clinical signs,
- against feline panleucopenia to prevent mortality and clinical signs,
- against leukaemia to prevent persistent viraemia and clinical signs of the related disease.
Onsets of immunity have been demonstrated 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component.
The duration of immunity is 1 year after the last (re-)vaccination for rhinotracheitis, calicivirus and feline leukaemia components, and 3 years for panleucopenia component.
|Marketing Authorisation Holder:||Merial
29 avenue Tony Garnier, 69007 Lyon, France
|EPAR and active package presentations|
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".|
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.
|Close date procedure||Procedure type||EMEA number||Decision||summary publ||decision docs||annex|
|25/02/2005||Centralised - Authorisation||EMEA/V/C/92/4||(2005)472 of 23/02/2005|
|18/07/2005||Centralised - Variation (no change in Commission Decision)||EMEA/V/C/92/II/1|
|25/01/2008||Centralised - Variation||EMEA/V/C/92/II/2, 3, 4||(2008)337 of 22/01/2008|
|22/09/2008||Centralised - Variation (no change in Commission Decision)||EMEA/V/C/92/II/5|
|16/02/2009||Centralised - Variation||EMEA/V/C/92/II/6||(2009)1067 of 12/02/2009|
|19/01/2010||Centralised - Renewal||EMEA/V/C/92/R/7||(2010)190 of 15/01/2010|
|12/02/2014||Centralised - Withdrawal (sunset clause)|